Lampert Mark N

Director, 10% owner at MLTX; Director, 10% owner at CELL THERAPEUTICS INC; 10% owner at PTN, and 4 more

Sold, on record
$143M
Dollars the filings state
Form 4 sales
7
Latest Mar 31, 2026
Form 144 notices
0
Proposed sales
Companies
7
Filed as an executive or holder

Companies

Sales by reason

0
Routine
3
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Mar 31, 2026Unusual

    MLTX

    Sold 78.3% of their holdings

    $63M3.8M shares at $16.79

    Filed Apr 2, 2026Form 4

  2. Aug 9, 2022Unusual

    CELL THERAPEUTICS INC

    Sold 99.8% of their holdings

    $52M8.5M shares at $6.12

    Filed Aug 11, 2022Form 4

  3. Feb 19, 2014Plan not stated

    PTN

    Sold 9.1% of their holdings

    $357k305,966 shares at $1.17

    Filed Feb 19, 2014Form 4

  4. Apr 1, 2010Unusual

    ARQULE INC

    Sold 43.8% of their holdings

    $22.9M3.8M shares at $6.11

    Filed Apr 2, 2010Form 4

  5. Nov 18, 2009Plan not stated

    AVIGEN INC \DE

    Sold under 0.1% of their holdings

    $939626 shares at $1.50

    Filed Nov 20, 2009Form 4

  6. Oct 21, 2009Unusual

    NEUROBIOLOGICAL TECHNOLOGIES INC /CA/

    Sold 93.3% of their holdings

    $4.2M4.6M shares at $0.91

    Filed Oct 23, 2009Form 4

  7. Sep 22, 2009Plan not stated

    ADOLOR CORP

    Sold 7.9% of their holdings

    $599k354,000 shares at $1.69

    Filed Sep 24, 2009Form 4

7 of 7

Every transaction

Every transaction on a Form 4 or Form 5 by Lampert Mark N
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 18, 2026Jun 23, 2026OLMADirectorAwardedStock Option (Right to buy)29,50029,500SEC
Mar 31, 2026Apr 2, 2026MLTXDirector, 10% ownerSold3.8M$16.79$63M1MSEC
Jun 15, 2023Jun 20, 2023KYMRDirectorAwardedStock Option (Right to Buy)12,00012,000SEC
Aug 9, 2022Aug 11, 2022CELL THERAPEUTICS INCDirector, 10% ownerSold8.5M$6.12$52M6,148SEC
Aug 9, 2022Aug 11, 2022CELL THERAPEUTICS INCDirector, 10% ownerConvertedSeries O Convertible Preferred Stock12,5750SEC
Aug 9, 2022Aug 11, 2022CELL THERAPEUTICS INCDirector, 10% ownerConverted8.4M1.5MSEC
Apr 26, 2021Apr 27, 2021Rain Oncology Inc.OtherAwarded1.1M$16.86$19.1M88,226SEC
Apr 23, 2021Apr 27, 2021Rain Oncology Inc.OtherConvertedSeries A Convertible Preferred Stock3.8M0SEC
Apr 23, 2021Apr 27, 2021Rain Oncology Inc.OtherConverted3.8M286,691SEC
Mar 30, 2021Apr 1, 2021Merus N.V.10% ownerBought300,000$19.75$5.9M462,015SEC
Mar 16, 2021Mar 18, 2021Merus N.V.10% ownerBought250,000$23.00$5.8M427,377SEC
Dec 22, 2020Dec 28, 2020ELDNOtherConvertedSeries X Convertible Preferred23,2136,758SEC
Dec 22, 2020Dec 28, 2020ELDNOtherConverted1.3M113,152SEC
Aug 21, 2020Aug 25, 2020KYMROtherConvertedSeries C Preferred Stock2.5M0SEC
Aug 21, 2020Aug 25, 2020KYMROtherConverted1.6M113,290SEC
Aug 21, 2020Aug 25, 2020KYMROtherAwarded978,693$20.00$19.6M181,081SEC
Aug 20, 2020Aug 25, 2020KYMROtherAwardedStock Option (Right to Buy)40,12740,127SEC
Mar 4, 2020Mar 4, 2020CELL THERAPEUTICS INC10% ownerBoughtSeries X Convertible Preferred Stock1,92112SEC
Mar 2, 2020Mar 4, 2020CELL THERAPEUTICS INC10% ownerExercised or settledSubscription Rights (right to buy)2,252104SEC
Dec 19, 2019Dec 20, 2019XOMA LTD /DE/10% ownerBought373,195$22.00$8.2M1.1MSEC
Dec 18, 2019Dec 20, 2019XOMA LTD /DE/10% ownerExercised or settledSubscription Rights (right to buy)472,2680SEC
Dec 18, 2019Dec 20, 2019XOMA LTD /DE/10% ownerExercised options472,268$22.00$10.4M159,537SEC
Nov 20, 2019Nov 22, 2019Calithera Biosciences, Inc.10% ownerBought191,954$3.91$751k672,682SEC
Nov 14, 2019Nov 18, 2019Calithera Biosciences, Inc.10% ownerBought128,488$3.37$433k658,531SEC
Oct 31, 2019Oct 31, 2019FIVE PRIME THERAPEUTICS INC10% ownerBought29,314$3.88$114k348,827SEC
Mar 27, 2018Mar 29, 2018XENE10% ownerOtherSeries 1 Preferred Shares2.4M238,000SEC
Mar 27, 2018Mar 29, 2018XENE10% ownerOther2.4M59,464SEC
Feb 9, 2018Feb 12, 2018CELL THERAPEUTICS INC10% ownerBought6.3M$3.00$19M1.3MSEC
Feb 9, 2018Feb 12, 2018CELL THERAPEUTICS INC10% ownerReturned to the companySeries N Preferred Stock5750SEC
Feb 9, 2018Feb 12, 2018CELL THERAPEUTICS INC10% ownerReturned to the company8M596,357SEC
Feb 9, 2018Feb 12, 2018CELL THERAPEUTICS INC10% ownerAwardedSeries O Preferred Stock12,5752,280SEC
Jun 22, 2017Jun 23, 2017XENE10% ownerBought20,411$4.00$82k288,968SEC
May 31, 2017Jun 1, 2017ALPINE IMMUNE SCIENCES, INC.10% ownerBought47,000$2.27$107k192,503SEC
Jul 1, 2014Jul 10, 2014ARRAY BIOPHARMA INCOtherOther494,092$4.56$2.3M7.1MSEC
Jul 1, 2014Jul 3, 2014CAPS10% ownerOther616,563$0.30$185k4MSEC
Feb 19, 2014Feb 19, 2014PTN10% ownerSold305,966$1.17$357k3.1MSEC
Aug 8, 2013Aug 12, 2013Oncothyreon Inc.10% ownerBought258,361$1.65$426k2.6MSEC
Jun 7, 2013Jun 11, 2013RIGL10% ownerBought32,700$3.47$113k799,615SEC
Nov 16, 2012Nov 19, 2012GYRE10% ownerBought1.3M$4.06$5.2M1.5MSEC
Nov 6, 2012Nov 8, 2012ChemoCentryx, Inc.10% ownerBought40,000$12.00$480k3.8MSEC
Nov 2, 2012Nov 2, 2012GYRE10% ownerBought139,700$4.05$566k1MSEC
Oct 31, 2012Nov 2, 2012LGND10% ownerBought16,591$15.19$252k741,627SEC
Oct 26, 2011Oct 28, 2011LGND10% ownerBought6,020$13.91$84k1.7MSEC
Oct 13, 2011Oct 14, 2011LGND10% ownerBought75,353$13.65$1M1.7MSEC
Sep 7, 2011Sep 9, 2011ICAGEN INC10% ownerBought126,700$6.00$760k625,400SEC
Aug 22, 2011Aug 22, 2011CAPS10% ownerBought78,900$0.26$21k4.4MSEC
Jul 20, 2011Jul 22, 2011CAPS10% ownerBought252,600$0.25$63k3.7MSEC
Jul 18, 2011Jul 18, 2011CAPS10% ownerBought358,600$0.25$90k3.5MSEC
May 9, 2011May 10, 2011Celera CORP10% ownerBought1.6M$8.05$12.7M15.8MSEC
Apr 6, 2011Apr 7, 2011Celera CORP10% ownerBought182,000$8.21$1.5M9.5MSEC
Page 1

Sales and notices (7)

Form 144 notices and Form 4 sales by Lampert Mark N
Source
Mar 31, 2026Apr 2, 2026MLTXDirector, 10% ownerForm 4 sale3.8M$63M78.3%UnusualSEC
Aug 9, 2022Aug 11, 2022CELL THERAPEUTICS INCDirector, 10% ownerForm 4 sale8.5M$52M99.8%UnusualSEC
Feb 19, 2014Feb 19, 2014PTN10% ownerForm 4 sale305,966$357k9.1%Plan not statedSEC
Apr 1, 2010Apr 2, 2010ARQULE INC10% ownerForm 4 sale3.8M$22.9M43.8%UnusualSEC
Nov 18, 2009Nov 20, 2009AVIGEN INC \DE10% ownerForm 4 sale626$9390.0%Plan not statedSEC
Oct 21, 2009Oct 23, 2009NEUROBIOLOGICAL TECHNOLOGIES INC /CA/10% ownerForm 4 sale4.6M$4.2M93.3%UnusualSEC
Sep 22, 2009Sep 24, 2009ADOLOR CORP10% ownerForm 4 sale354,000$599k7.9%Plan not statedSEC